Form 4: Korro Bio Director and 10% Owner Ali Behbahani Granted Stock Options

Korro Bio, Inc. announced that Director and 10% Owner Ali Behbahani was granted 6,010 stock options with an exercise price of $14.87, vesting on the earlier of one year from the grant date or the next annual meeting.

Summary

• Ali Behbahani, a Director and 10% Owner of Korro Bio, Inc. (KRRO), was granted 6,010 stock options.
• The stock options have an exercise price of $14.87 per share.
• The grant date for these options was June 11, 2025.
• The options are set to expire on June 10, 2035.
• Vesting occurs in full on the earlier of the one-year anniversary of the grant date (June 11, 2026) or the date of the next annual meeting of stockholders, contingent on continued service as a non-employee director.

Sentiment

Score: 7

Explanation: The document reports a standard insider transaction (stock option grant) which is generally a neutral to slightly positive event as it aligns director incentives with shareholder value. There are no negative disclosures.

Positives

• The grant of stock options to a director aligns the director's interests with those of the shareholders, incentivizing long-term value creation.
• The options serve as a form of compensation for continued service as a non-employee director.

Industry Context

Korro Bio, Inc. operates in the biotechnology sector, focusing on genetic medicines. Stock option grants to directors are a common practice in this industry to attract and retain talent, aligning their interests with the company's long-term success and shareholder value.

Related Party Transactions

• The grant of stock options to Ali Behbahani, a Director and 10% Owner, constitutes a transaction with a related party, which is a standard form of compensation for board service.

Stakeholder Impact

• Shareholders: The option grant aligns the director's financial interests with those of the shareholders, potentially encouraging decisions that enhance long-term stock value.

Next Steps

• The options will vest on the earlier of the one-year anniversary of the grant date or the next annual meeting of stockholders, subject to continued service.

Key Dates

Keywords

Korro Bio, KRRO, SEC Form 4, Insider Transaction, Stock Option, Director Compensation, Ali Behbahani, Equity Grant, Beneficial Ownership, Biotechnology